Dr. Jean Dorthy Hermsen, DO Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Avenue, Mcfarland Clinic Pc, Ames, IA 50010 Phone: 515-239-4480 Fax: 515-239-4716 |
Lindsay Jo Sturm, D.O. Otolaryngology Medicare: Medicare Enrolled Practice Location: 2122 Leopold Dr, Ames, IA 50010 Phone: 320-333-3190 |
Dr. Arthur F. Chen, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Avenue, Ames, IA 50010 Phone: 515-239-4480 Fax: 515-239-4716 |
Dr. Austin Bancroft, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1215 Duff Avenue, Ames, IA 50010 Phone: 515-239-4480 Fax: 515-239-4716 |
Dr. Charles Douglas Jons, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2916 Forest Hills Dr, Ames, IA 50014 Phone: 515-292-9686 |
Dr. Thomas Edwin Smith Jr., M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1215 Duff Ave, Ames, IA 50010 Phone: 515-239-4480 Fax: 515-239-4539 |
News Archive
Women planning on taking hormone therapy for the treatment of menopausal symptoms should be aware of a possible increased risk for ovarian cancer, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
Although Republicans will meet with President Obama tomorrow for a health care summit - supposedly to negotiate a bipartisan agreement for health care reform - Institute for Policy Innovation (IPI) health care expert Dr. Merrill Matthews says the president's plan does nothing to appease the other side of the aisle
A study of 40 overweight children in Edmonton has revealed they all share something in common aside from being heavy: each one of them has high levels of apoB48, a structural protein found in intestinal cholesterol.
With market conditions expected to fluctuate in the wake of healthcare reform, hospitals can now quickly and easily evaluate their pricing strategy with Value-based Pricing Analyzer™, a new offering from Craneware, Inc., the market leader in automated revenue integrity solutions.
Treatment with denosumab 60 mg and 180 mg (with background methotrexate) reduces the progression of bone erosion according to results of a 227 patient Phase II trial presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.
› Verified 5 days ago